Working… Menu

Predicting Response to Immunotherapy for Melanoma With Gut Microbiome and Metabolomics (PRIMM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03643289
Recruitment Status : Recruiting
First Posted : August 22, 2018
Last Update Posted : February 27, 2020
King's College London
Information provided by (Responsible Party):
East and North Hertfordshire NHS Trust

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : May 2, 2023
Estimated Study Completion Date : May 2, 2023